We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$137M
AUM Growth
+$16.5M
Cap. Flow
+$772K
Cap. Flow %
0.56%
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34

Top Buys

Rank Stock Value
1
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
+$3.12M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$3.04M
3
MXIM
Maxim Integrated Products
MXIM
+$2.88M
4
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$2.01M
5
STRO icon
Sutro Biopharma
STRO
+$611K

Top Sells

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$7.91M
2
CZR
Caesars Entertainment Corporation
CZR
+$4.15M
3
LOGM
LogMein, Inc.
LOGM
+$2.89M
4
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$548K
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$505K

Sector Composition

Rank Sector Weight
1 Technology 36.76%
2 Healthcare 21.07%
3 Financials 13.05%
4 Consumer Discretionary 10.17%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMVT icon
26
Immunovant
IMVT
$8.33B
$630K 0.46%
+17,905
New +$539K
FMTX
27
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$614K 0.45%
+12,325
New +$498K
KOD icon
28
Kodiak Sciences
KOD
$2.67B
$598K 0.44%
10,097
+1,258
+14% +$63.1K
TGTX icon
29
TG Therapeutics
TGTX
$7.65B
$576K 0.42%
21,538
-4,731
-18% -$109K
STOK icon
30
Stoke Therapeutics
STOK
$2.12B
$572K 0.42%
17,082
-652
-4% -$18.6K
INSM icon
31
Insmed
INSM
$29.3B
$567K 0.41%
17,635
+1,729
+11% +$49.7K
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$565K 0.41%
3,400
-177
-5% -$24.2K
DNLI icon
33
Denali Therapeutics
DNLI
$4.02B
$564K 0.41%
+15,734
New +$474K
SAGE
34
DELISTED
Sage Therapeutics
SAGE
$561K 0.41%
+9,182
New +$465K
XNCR icon
35
Xencor
XNCR
$1.64B
$555K 0.4%
+14,315
New +$497K
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
$555K 0.4%
+7,421
New +$495K
DBC icon
37
Invesco DB Commodity Index Tracking Fund
DBC
$1.72B
$554K 0.4%
42,396
– –
IOVA icon
38
Iovance Biotherapeutics
IOVA
$2.92B
$554K 0.4%
16,824
+1,343
+9% +$41.2K
FATE icon
39
Fate Therapeutics
FATE
$318M
$552K 0.4%
13,807
+1,344
+11% +$46.9K
SWTX
40
DELISTED
SpringWorks Therapeutics
SWTX
$547K 0.4%
11,477
+828
+8% +$35.3K
DCPH
41
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$543K 0.4%
10,583
+2,866
+37% +$140K
ISEE
42
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$541K 0.39%
+95,975
New +$458K
ARGX icon
43
argenx
ARGX
$53.9B
$540K 0.39%
2,058
+186
+10% +$44.7K
MBT
44
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$526K 0.38%
60,200
+17,400
+41% +$158K
MTEM
45
DELISTED
Molecular Templates, Inc.
MTEM
$517K 0.38%
+3,158
New +$561K
CCXI
46
DELISTED
ChemoCentryx, Inc.
CCXI
$515K 0.38%
9,395
-374
-4% -$20.1K
ACAD icon
47
Acadia Pharmaceuticals
ACAD
$5.09B
$513K 0.37%
12,429
+3,635
+41% +$157K
ASND icon
48
Ascendis Pharma A/S
ASND
$16.7B
$510K 0.37%
3,307
+414
+14% +$59.5K
BDTX icon
49
Black Diamond Therapeutics
BDTX
$117M
$496K 0.36%
+16,391
New +$499K
NVO
50
Novo Nordisk
NVO
$206B
$493K 0.36%
14,200
-600
-4% -$20K
1
2
3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
BCC
Bridge City Capital Lake Oswego, Oregon $361M AUM 38.29% 1-Year Est. Return

HighVista Strategies's Q3 2020 Portfolio in Review

As of Q3 2020, HighVista Strategies held 147 positions worth $137M, up 14% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HighVista Strategies's Q3 2020 filing shows 47 new, 29 increased, 15 reduced and 34 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M. The largest sale was Tech Data Corp, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q3 2020 buy was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M.
  • HighVista Strategies added most to Xenon Pharmaceuticals in Q3 2020, an estimated $274K increase.
  • HighVista Strategies's biggest Q3 2020 reduction was Kadmon Holdings, Inc., cutting an estimated $256K.
  • HighVista Strategies fully exited Tech Data Corp in Q3 2020, selling an estimated $7.91M.
  • HighVista Strategies's ten largest holdings make up 69% of its $137M portfolio in Q3 2020.
  • HighVista Strategies opened 47 new positions and closed 34 in Q3 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $137M.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.